FR2868841B1 - Methode d'identification de composes actifs sur la replication du virus hiv - Google Patents

Methode d'identification de composes actifs sur la replication du virus hiv

Info

Publication number
FR2868841B1
FR2868841B1 FR0403782A FR0403782A FR2868841B1 FR 2868841 B1 FR2868841 B1 FR 2868841B1 FR 0403782 A FR0403782 A FR 0403782A FR 0403782 A FR0403782 A FR 0403782A FR 2868841 B1 FR2868841 B1 FR 2868841B1
Authority
FR
France
Prior art keywords
replication
active compounds
hiv virus
identifying active
identifying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0403782A
Other languages
English (en)
Other versions
FR2868841A1 (fr
Inventor
Christian Auclair
Frederic Subra
Jean Francois Mouscadet
Valerie Polard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Bioalliance Pharma SA
Ecole Normale Superieure de Cachan
Original Assignee
Centre National de la Recherche Scientifique CNRS
Bioalliance Pharma SA
Ecole Normale Superieure de Cachan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Bioalliance Pharma SA, Ecole Normale Superieure de Cachan filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR0403782A priority Critical patent/FR2868841B1/fr
Priority to PCT/FR2005/000874 priority patent/WO2005103654A2/fr
Publication of FR2868841A1 publication Critical patent/FR2868841A1/fr
Application granted granted Critical
Publication of FR2868841B1 publication Critical patent/FR2868841B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G01N2333/163—Regulatory proteins, e.g. tat, nef, rev, vif, vpu, vpr, vpt, vpx
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FR0403782A 2004-04-09 2004-04-09 Methode d'identification de composes actifs sur la replication du virus hiv Expired - Fee Related FR2868841B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0403782A FR2868841B1 (fr) 2004-04-09 2004-04-09 Methode d'identification de composes actifs sur la replication du virus hiv
PCT/FR2005/000874 WO2005103654A2 (fr) 2004-04-09 2005-04-11 Methode d’identification de composes actifs sur la replication du virus hiv.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0403782A FR2868841B1 (fr) 2004-04-09 2004-04-09 Methode d'identification de composes actifs sur la replication du virus hiv

Publications (2)

Publication Number Publication Date
FR2868841A1 FR2868841A1 (fr) 2005-10-14
FR2868841B1 true FR2868841B1 (fr) 2006-07-14

Family

ID=34944932

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0403782A Expired - Fee Related FR2868841B1 (fr) 2004-04-09 2004-04-09 Methode d'identification de composes actifs sur la replication du virus hiv

Country Status (1)

Country Link
FR (1) FR2868841B1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0753006A4 (fr) * 1994-03-25 1999-04-14 Biomolecular Res Inst Ltd PROTEINES Vpr ET Vpx DU VIH
US5639619A (en) * 1994-10-13 1997-06-17 Regents Of The University Of California Screening assay for anti-HIV drugs using the Vpr gene

Also Published As

Publication number Publication date
FR2868841A1 (fr) 2005-10-14

Similar Documents

Publication Publication Date Title
ITMI20042393A1 (it) Procedimento per la fabbricazione di un componente a semiconduttore nonche' un componente a semiconduttore in particolare un sensore a membrana
IS2940B (is) Mótefni gegn CD40
NO20016368L (no) Respiratorisk syncytialvirus-replikasjonsinhibitorer
NO20016369L (no) Respiratorisk syncytialvirus-replikasjonsinhibitorer
NO20016370D0 (no) Respiratorisk syncytialvirus-replikasjonsinhibitorer
ITRE20050009A1 (it) Dispositivo medico antireflusso basato sull'azione di magneti
BR0310115B1 (pt) processo para preparaÇço de dinitrilas de Ácido fenilmalânico.
CL2004000261A1 (es) Procedimiento para la eliminacion de virus en soluciones de fibrinogeno de aplicacion terapeutica.
DE60328456D1 (de) Eine kontinuierliche zellinie zur herstellung von impfstoffen
FR2868841B1 (fr) Methode d'identification de composes actifs sur la replication du virus hiv
DE112004000806D2 (de) Phenol urea/melamineformaldehydecopolymers, method for the production thereof and use of the same
DE60131170D1 (de) Künstliche Lunge des Membrantyps
ITRM20010332A0 (it) Vaccini a subunita' e procedimenti per la loro produzione.
ES1053224Y (es) Aparejo para la recogida de excrementos de caballerias.
ITMI20042402A1 (it) Processo per la preparazione di n,n-dimetil-n'-feniluree
ITBZ20040033A1 (it) Impianto di rilevamento dell'umidita'.
FI20031065A (fi) Hyönteissuoja-aine, menetelmä sen valmistamiseksi ja sen käyttö
FR2866666B1 (fr) About d'echafaudage
ITMI20040873A1 (it) Processo di preparazione di 3-3,4 metilendiossi-fenil-2-metilpropanale
ITUD20060244A1 (it) Metodo per la realizzazione di una struttura sportiva multifunzionale, e struttura sportiva multifunzionale cosi' realizzata
ITMI20031849A1 (it) Procedimento per la realizzazione di elementi a ventosa, nonche' elemento a ventosa ottenuto e manufatto con ventosa.
ES1054316Y (es) "forjado nervado"
FR2894595B1 (fr) Methode pour identifier un compose cosmetiquement actif capable d'agir sur les pre-adipocytes
ITPT20050006A1 (it) Procedimento e metodo per la formazione di filati fantasia e filati cosi' ottenuti
ITRM20030440A0 (it) Sistema d'indicazione temporale, in particolare dell'orario.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20141231